Article
circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in…
OncoTargets and Therapy · 2018 · Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC
Key facts
| Title | circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma |
|---|---|
| First author | Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC |
| Journal | OncoTargets and Therapy |
| Published | May 16, 2018 |
| DOI | 10.2147/OTT.S158008 |
| Devices mentioned | K071580, K071681, K182886, K925155 |
| Product codes mentioned | CEK, CIT, GKZ, NSU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1